Showing results (91-100 of 322) with videos related to
Sort By:
Pageof 33
Seminars in Thrombosis and Hemostasis|February 14, 2018
Inhibitors in Nonsevere Hemophilia A: What Is Known and Searching for the UnknownAmal Abdi, Silvia Linari, Lisa Pieri, et al.Leukemia Research|May 2, 2017
Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of HematologyPaola Guglielmelli, Daniela Pietra, Fabrizio Pane, et al.American Journal of Hematology|April 3, 2016
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM groupGiada Rotunno, Annalisa Pacilli, Valentina Artusi, et al.Haematologica|February 13, 2008
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatmentsValerio De Stefano, Tommaso Za, Elena Rossi, et al.Blood Cancer Journal|January 18, 2024
One thousand patients with essential thrombocythemia: the Florence-CRIMM experienceGiuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, et al.Blood|July 3, 2014
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosisElisa Rumi, Daniela Pietra, Cristiana Pascutto, et al.Blood Cancer Journal|November 14, 2018
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 casesValerio De Stefano, Elena Rossi, Alessandra Carobbio, et al.Blood Cancer Journal|August 10, 2019
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paperTiziano Barbui, Valerio De Stefano, Anna Falanga, et al.Blood Cancer Journal|February 11, 2018
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussionTiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.Pageof 33